subcutaneous interferon beta therapy multiple sclerosis (MS)
Showing 1 - 25 of >10,000
Multiple Sclerosis Trial in Cairo (Blood sample collection)
Recruiting
- Multiple Sclerosis
- Blood sample collection
-
Cairo, EgyptNasser Institute for Research and Treatment
Feb 21, 2023
Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Trial in Warsaw (Cladribine Subcutaneous Injection, 0.9% Chloride
Recruiting
- Multiple Sclerosis, Secondary Progressive
- Multiple Sclerosis
- Cladribine Subcutaneous Injection
- 0.9% Chloride Injection Sodium
-
Warsaw, Mazowieckie, PolandInstitute of Psychiatry and Neurology
Jul 26, 2023
Multiple Sclerosis Trial in Shreveport (Interferon beta 1a, oral doxycycline)
Completed
- Multiple Sclerosis
- Interferon beta 1a, oral doxycycline
-
Shreveport, LouisianaLSU Health Sciences Center Shreveport
Oct 11, 2022
Multiple Sclerosis Trial (Diroximel Fumarate, Avonex, Tysabri)
Not yet recruiting
- Multiple Sclerosis
- Diroximel Fumarate
- +3 more
- (no location specified)
Dec 12, 2022
Learn About Interferon-beta Exposure of Pregnant Women During
Not yet recruiting
- Multiple Sclerosis (MS)
- Avonex (IFNβ-1-a, Biogen Netherlands B.V)
- +5 more
-
Multiple Locations, Finland
- +1 more
Sep 19, 2023
Female Participants Exposed to Subcutaneous Peginterferon
Completed
- Multiple Sclerosis
- Multiple Sclerosis, Relapsing-Remitting
- Interferon Beta Therapy
-
Göttingen, GermanyResearch Site
Nov 1, 2021
MS Trial in Giza (strengthening ex with BFR training, strengthening ex)
Recruiting
- MS
- strengthening ex with BFR training
- strengthening ex
-
Giza, EgyptFaculty of physical therapy
Nov 16, 2023
Relapsing Remitting Multiple Sclerosis Trial in Portugal (peginterferon beta-1a, interferon beta-1a, interferon beta-1b)
Completed
- Relapsing Remitting Multiple Sclerosis
- peginterferon beta-1a
- +2 more
-
Amadora, Portugal
- +14 more
Nov 23, 2020
Multiple Sclerosis (MS) Patients
Not yet recruiting
- Multiple Sclerosis, Relapsing-Remitting
- +2 more
- (no location specified)
Dec 15, 2022
Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive Trial in San Francisco
Not yet recruiting
- Multiple Sclerosis (MS)
- +6 more
- Clemastine Fumarate
- Placebo
-
San Francisco, CaliforniaSandler Neurosciences Building, Neurological Clinical Research U
Jan 23, 2023
MS (Multiple Sclerosis) Trial in Bursa (Deep sensory assisted rehabilitation, classical rehabilitation)
Active, not recruiting
- MS (Multiple Sclerosis)
- Deep sensory assisted rehabilitation
- classical rehabilitation
-
Bursa, Yildirim, Turkey
- +1 more
Aug 7, 2023
Relapsing Remitting Multiple Sclerosis (RRMS) Trial in Tehran (Pegylated interferon beta-1a, Interferon Beta-1A Prefilled
Active, not recruiting
- Relapsing Remitting Multiple Sclerosis (RRMS)
- Pegylated interferon beta-1a
- Interferon Beta-1A Prefilled Syringe
-
Tehran, Iran, Islamic Republic ofSina Hospital
Feb 5, 2022
Assess Adherence to Treatment for Patients With RMS (MAIN-MS)
Completed
- Relapsing Multiple Sclerosis (RMS)
- Rebif (Interferon beta-1a)
-
Alger, Algeria
- +40 more
Mar 22, 2022
Multiple Sclerosis, Urinary Bladder, Overactive Trial in San Francisco (WeB, Standard pelvic floor physical therapy)
Not yet recruiting
- Multiple Sclerosis
- Urinary Bladder, Overactive
- WeB
- Standard pelvic floor physical therapy
-
San Francisco, CaliforniaUniversity of California San Francisco, Weill Institute for Neur
Jan 27, 2023
Multiple Sclerosis Trial in Aarhus (Walking exercise therapy)
Recruiting
- Multiple Sclerosis
- Walking exercise therapy
-
Aarhus, Jutland, DenmarkAarhus University, Health, Exercise Biology
Jun 10, 2022
Relapsing-remitting Multiple Sclerosis Trial in Stockholm (Rituximab)
Active, not recruiting
- Relapsing-remitting Multiple Sclerosis
-
Stockholm, SwedenFredrik Piehl
Apr 8, 2022
Multiple Sclerosis Trial in Ann Arbor (PAP therapy)
Completed
- Multiple Sclerosis
- PAP therapy
-
Ann Arbor, MichiganUniversity of Michigan Medical Center
Aug 18, 2022
Program Study for Improvement of Gait in People With Multiple
Not yet recruiting
- Gait Impairment Due to Mild/Moderate Multiple Sclerosis (MS)
- PoNS®
- (no location specified)
Jun 23, 2022
Relapsing Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in United
Recruiting
- Relapsing Multiple Sclerosis
- +2 more
- Autologous Hematopoietic Stem Cell Transplantation
- Best Available Therapy (BAT)
-
Palo Alto, California
- +20 more
Jan 25, 2023
Multiple Sclerosis Trial in Overpelt (Dance therapy, Psychometric properties (Validity, Reliability) of interlimb coordination-
Recruiting
- Multiple Sclerosis
- Dance therapy
- Psychometric properties (Validity, Reliability) of interlimb coordination- and cognitive-fatigability
-
Overpelt, Belgium
- +1 more
Jun 6, 2022
MS (Multiple Sclerosis), Erythema Trial in Kirkland (Warm Compress Before Injection, Cold Compress After Injection)
Completed
- MS (Multiple Sclerosis)
- Erythema
- Warm Compress Before Injection
- Cold Compress After Injection
-
Kirkland, WashingtonEvergreen Health
Mar 10, 2022
Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting Trial in Germany, United States (Tetanus, diphtheria, and acellular
Recruiting
- Multiple Sclerosis
- Multiple Sclerosis, Relapsing-Remitting
- Tetanus, diphtheria, and acellular pertussis vaccine
- +2 more
-
Palo Alto, California
- +47 more
Jun 24, 2022
Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Primary Progressive Trial in Kaposvár (Training groupe, PNF,
Completed
- Multiple Sclerosis, Chronic Progressive
- Multiple Sclerosis, Primary Progressive
- Training groupe
- +3 more
-
Kaposvár, Somogy, HungarySomogy Megyei Kaposi Mór Oktató Kórház
Mar 24, 2022